Bacterial vaginosis (BV) is a common but often uncomfortable vaginal infection. Once doctors diagnose BV, it is easily treatable. The first step is determining whether you have it. Read on to learn ...
Bacterial vaginosis (BV) is the most common vaginal infection in women. According to the Centers for Disease Control and Prevention (CDC), the condition affects nearly 30% of women between 15 and 44 ...
Alternative Therapies BV introduces a new series of skincare boxes, focusing on anti-aging, dermatological solutions, and ...
Bacterial vaginosis (BV) is an infection that develops due to an imbalance in the natural bacteria in the vagina. It occurs when “bad” bacteria, which do not need oxygen to survive, outnumber “good” ...
Bacterial vaginosis (BV) and vaginal yeast infections can both cause pain and discomfort, difficulty urinating, and itching. Other symptoms, such as vaginal discharge, may differ. Treatment will ...
Share on Pinterest Bacterial vaginosis (BV) is not classified as a sexually transmitted infection, but the results of a new study could change that. ljubaphoto/Getty Images New research suggests a ...
Bacterial vaginosis (BV) is the most common vaginal condition among women of reproductive age, yet it’s still cloaked in silence. The cycle of symptoms (itching, discharge, odor) and the emotional ...
Roche has secured CE Mark approval for its cobas BV/CV assay to support the diagnosis of infectious causes of vaginitis.
Bacterial vaginosis, commonly known as BV, is the most common vaginal infection. Nearly 30% of women in the U.S. will experience bacterial vaginosis at some point in their lifetime. Bacterial ...
Bacterial vaginosis (BV) affects 1 in 3 women, causing embarrassment and discomfort. However, according to a recent study, BV occurs in nearly 29% of 14‐ to 49‐year‐old women in the United States, ...
Ask a woman for the most frustrating and uncomfortable health condition she’s ever dealt with down there, and bacterial vaginosis (BV) likely tops the list. And, if you keep getting BV, it’s ...
Over the past six months, BrightView’s stock price fell to $12.73. Shareholders have lost 18.1% of their capital, which is ...